Implication of the CD47 pathway in autoimmune diabetes

Journal of Autoimmunity

Volumn 35, Issue 1, 2010, Pages 23-32

  Dugas, Véronique ^a,b   Beauchamp, Claudine ^a,b   Chabot Roy, Geneviève ^a   Hillhouse, Erin E ^a,b   Lesage, Sylvie ^a,b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Autoimmune diabetes; CD47; Signal regulatory protein; T cells; Tolerance; Transgenic mice

Indexed keywords

CD47 ANTIGEN; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN; UNCLASSIFIED DRUG; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BINDING; PTPNS1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; CD4 CD8 RATIO; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD47; ANTIGENS, CD8; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 77953289018     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.01.002     Document Type: Article

References (67)

1. Brown E.J., Frazier W.A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001, 11:130-135.
2. Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J., et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 2001, 167:2547-2554.
3. Brooke G., Holbrook J.D., Brown M.H., Barclay A.N. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J Immunol 2004, 173:2562-2570.
4. Pettersen R.D. CD47 and death signaling in the immune system. Apoptosis 2000, 5:299-306.
5. Ticchioni M., Deckert M., Mary F., Bernard G., Brown E.J., Bernard A. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J Immunol 1997, 158:677-684.
6. Waclavicek M., Majdic O., Stulnig T., Berger M., Baumruker T., Knapp W., et al. T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4. J Immunol 1997, 159:5345-5354.
7. Seiffert M., Brossart P., Cant C., Cella M., Colonna M., Brugger W., et al. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood 2001, 97:2741-2749.
8. de Vries H.E., Hendriks J.J., Honing H., De Lavalette C.R., van der Pol S.M., Hooijberg E., et al. Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J Immunol 2002, 168:5832-5839.
9. Liu Y., Buhring H.J., Zen K., Burst S.L., Schnell F.J., Williams I.R., et al. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem 2002, 277:10028-10036.
10. Van V.Q., Lesage S., Bouguermouh S., Gautier P., Rubio M., Levesque M., et al. Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs. Embo J 2006, 25:5560-5568.
11. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005, 123:321-334.
12. Beattie L., Svensson M., Bune A., Brown N., Maroof A., Zubairi S., et al. Leishmania donovani-induced expression of SIRPalpha on kupffer cells enhances hepatic invariant NKT cell activation. Eur J Immunol 2009.
13. Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I., Barclay A.N. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell 2008, 31:266-277.
14. Barclay A.N. Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. Curr Opin Immunol 2009, 21:47-52.
15. Kvansakul M., Adams J.C., Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J 2004, 23:1223-1233.
16. van Beek E.M., Cochrane F., Barclay A.N., van den Berg T.K. Signal regulatory proteins in the immune system. J Immunol 2005, 175:7781-7787.
17. Barclay A.N., Brown M.H. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006, 6:457-464.
18. Barclay A.N., Hatherley D. The counterbalance theory for evolution and function of paired receptors. Immunity 2008, 29:675-678.
19. Piccio L., Vermi W., Boles K.S., Fuchs A., Strader C.A., Facchetti F., et al. Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation. Blood 2005, 105:2421-2427.
20. Ichigotani Y., Matsuda S., Machida K., Oshima K., Iwamoto T., Yamaki K., et al. Molecular cloning of a novel human gene (SIRP-B2) which encodes a new member of the SIRP/SHPS-1 protein family. J Hum Genet 2000, 45:378-382.
21. Stefanidakis M., Newton G., Lee W.Y., Parkos C.A., Luscinskas F.W. Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro. Blood 2008, 112:1280-1289.
22. Tomizawa T., Kaneko Y., Saito Y., Ohnishi H., Okajo J., Okuzawa C., et al. Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 mutant mice. J Immunol 2007, 179:869-877.
23. Okuzawa C., Kaneko Y., Murata Y., Miyake A., Saito Y., Okajo J., et al. Resistance to collagen-induced arthritis in SHPS-1 mutant mice. Biochem Biophys Res Commun 2008, 371:561-566.
24. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science 2000, 288:2051-2054.
25. Oldenborg P.A., Gresham H.D., Chen Y., Izui S., Lindberg F.P. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 2002, 99:3500-3504.
26. Wallis R.H., Wang K., Marandi L., Hsieh E., Ning T., Chao G.Y., et al. Type 1 diabetes in the BB rat: a polygenic disease. Diabetes 2009, 58:1007-1017.
27. Serreze D.V., Prochazka M., Reifsnyder P.C., Bridgett M.M., Leiter E.H. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 1994, 180:1553-1558.
28. Takenaka K., Prasolava T.K., Wang J.C., Mortin-Toth S.M., Khalouei S., Gan O.I., et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007, 8:1313-1323.
29. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009.
30. Guimont-Desrochers F., Beauchamp C., Chabot-Roy G., Dugas V., Hillhouse E.E., Dusseault J., et al. Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes. Int Immunol 2009, 21:167-177.
31. Zhang Z.X., Yang L., Young K.J., DuTemple B., Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000, 6:782-789.
32. Priatel J.J., Utting O., Teh H.S. TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J Immunol 2001, 167:6188-6194.
33. Chen W., Ford M.S., Young K.J., Zhang L. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses. Cell Mol Immunol 2004, 1:328-335.
34. Fischer K., Voelkl S., Heymann J., Przybylski G.K., Mondal K., Laumer M., et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 2005, 105:2828-2835.
35. Ho W.Y., Cooke M.P., Goodnow C.C., Davis M.M. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med 1994, 179:1539-1549.
36. Akkaraju S., Ho W.Y., Leong D., Canaan K., Davis M.M., Goodnow C.C. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 1997, 7:255-271.
37. Lesage S., Hartley S.B., Akkaraju S., Wilson J., Townsend M., Goodnow C.C. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 2002, 196:1175-1188.
38. Lindberg F.P., Bullard D.C., Caver T.E., Gresham H.D., Beaudet A.L., Brown E.J. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996, 274:795-798.
39. Van Parijs L., Peterson D.A., Abbas A.K. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 1998, 8:265-274.
40. Weston S.A., Parish C.R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 1990, 133:87-97.
41. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
42. Van V.Q., Darwiche J., Raymond M., Lesage S., Bouguermouh S., Rubio M., et al. Cutting edge: CD47 controls the in vivo proliferation and homeostasis of peripheral CD4+ CD25+ Foxp3+ regulatory T cells that express CD103. J Immunol 2008, 181:5204-5208.
43. - cell population. J Immunol 1992, 148:3746-3752.
44. - surface phenotype and the alpha, beta heterodimer of the T cell antigen receptor. J Immunol 1989, 143:1118-1122.
45. Egawa T., Kreslavsky T., Littman D.R., von Boehmer H. Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping. PLoS ONE 2008, 3:e1512.
46. -T cells that escape deletion and lack regulatory activity. J Immunol 2003, 170:201-209.
47. Illes Z., Waldner H., Reddy J., Anderson A.C., Sobel R.A., Kuchroo V.K. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background. Int Immunol 2007.
48. Fritsch M., Andersson A., Petersson K., Ivars F. A TCR alpha chain transgene induces maturation of CD4- CD8- alpha beta+ T cells from gamma delta T cell precursors. Eur J Immunol 1998, 28:828-837.
49. Zhang Z.X., Ma Y., Wang H., Arp J., Jiang J., Huang X., et al. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, fas-fas ligand-independent pathway. J Immunol 2006, 177:6920-6929.
50. Zhang Z.X., Stanford W.L., Zhang L. Ly-6A is critical for the function of double negative regulatory T cells. Eur J Immunol 2002, 32:1584-1592.
51. Lee B.P., Mansfield E., Hsieh S.C., Hernandez-Boussard T., Chen W., Thomson C.W., et al. Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol 2005, 174:4535-4544.
52. Leng Q., Ge Q., Nguyen T., Eisen H.N., Chen J. Stage-dependent reactivity of thymocytes to self-peptide-MHC complexes. Proc Natl Acad Sci USA 2007, 104:5038-5043.
53. Baldwin T.A., Hogquist K.A., Jameson S.C. The fourth way? harnessing aggressive tendencies in the thymus. J Immunol 2004, 173:6515-6520.
54. Anderson M.S., Bluestone J.A. THE NOD MOUSE: a model of immune dysregulation. Annu Rev Immunol 2005, 23:447-485.
55. Maier L.M., Wicker L.S. Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 2005, 17:601-608.
56. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435:224-228.
57. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005, 435:220-223.
58. von Herrath M. Immunology: insulin trigger for diabetes. Nature 2005, 435:151-152.
59. Krishnamurthy B., Dudek N.L., McKenzie M.D., Purcell A.W., Brooks A.G., Gellert S., et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006, 116:3258-3265.
60. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007, 39:329-337.
61. Fife B.T., Griffin M.D., Abbas A.K., Locksley R.M., Bluestone J.A. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J Clin Invest 2006, 116:2252-2261.
62. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995, 13:179-200.
63. Yui M.A., Muralidharan K., Moreno-Altamirano B., Perrin G., Chestnut K., Wakeland E.K. Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic dissection of complex traits. Mamm Genome 1996, 7:331-334.
64. Wang H., Madariaga M.L., Wang S., Van Rooijen N., Oldenborg P.A., Yang Y.G. Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells. Proc Natl Acad Sci USA 2007, 104:13744-13749.
65. Chen W., Ford M.S., Young K.J., Cybulsky M.I., Zhang L. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003, 170:1846-1853.
66. Chen W., Ford M.S., Young K.J., Zhang L. Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant Proc 2003, 35:2479-2480.
67. Ford M.S., Chen W., Wong S., Li C., Vanama R., Elford A.R., et al. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur J Immunol 2007.